Can Romiplostim Reduce Chemo Disruptions in GI Cancer?

A recent analysis assesses whether romiplostim can reduce thrombocytopenia-driven chemotherapy dose reductions, delays, and discontinuations.
Medscape Medical News

source https://www.medscape.com/viewarticle/can-romiplostim-reduce-chemotherapy-disruptions-gi-cancer-2026a10008hr?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension